Table 3.

Tumor sites used for molecular testing

	Molecular Cohort
Test(s) Performed	ALK+	EGFR+	KRAS+	Triple Negative	Total Number
Primary	18	17	24	45	104
Lymph Node	10	4	3	11	28
Metastatic site	10	13	20	22	65
Primary + other site	0	1	1	1	3
Primary with multiple biopsies	0	1	0	0	1
Multiple metastatic site biopsied	3	3	1	1	8
Total	41	39	49	80	209